Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000245408 | SCV000319688 | likely benign | Cardiovascular phenotype | 2015-06-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000550430 | SCV000627750 | benign | Long QT syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001534470 | SCV001751403 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253339 | SCV002524854 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001534470 | SCV004164292 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | AKAP9: BS1, BS2 |